Title: Immunotherapy for malignant glioma using lentivirally transduced dendritic cells in an experimental murine model
Authors: Maes, Wim
Toelen, Jaan
Carlon, Marianne
Gijsbers, Rik
Debyser, Zeger
Cuppens, Jan
Van Gool, Stefaan #
Issue Date: Oct-2008
Publisher: Mary Ann Liebert, Inc.
Host Document: Human gene therapy vol:19 issue:10 pages:1101-1101
Conference: ESGCT Meeting location:Brugge, Belgium date:13-16 November 2008
Abstract: Background: Effective induction of systemic cellular antitumor immunity is crucial for immunotherapeutic gene therapy against intracerebral gliomas. We examined in this study the in vivo efficacy of prophylactic subcutaneous (s.c.) immunization with dendritic cells (DC) transduced with lentiviral vectors (LV) in the GL261 orthotopic glioma model. Moreover, immune monitoring on brain infiltrating lymphocytes was performed.
Methods: VSV-G pseudotyped LV encoding eGFP driven by a CMV promoter (LV-eGFP) were produced in 293T cells under serum free conditions. Bone-marrow derived mouse DC were transduced ex vivo with these LV and matured with LPS. C57BL/6 mice were vaccinated with a s.c. injection of 1x106 DC and were subsequently stereotactically injected with GL261 glioma cells expressing eGFP. Control mice were left untreated. In both groups mice were sacrificed at day 5 (early) and day 30 (late) after tumor challenge: time points and tumor infiltrating lymphocytes were analysed by flowcytometry. Animals were clinically monitored for tumor-induced neurologic deficit and mortality was compared between the two groups.
Results and Conclusion: Although not protective, survival of DC treated mice was significantly prolonged compared to untreated animals (Logrank p<0.001). Both early and late immune monitoring revealed a significant increase in the absolute number of brain infiltrating lymphocytes. Moreover, total CD4+ and CD8+ as well as activated (CD44+) CD4+ and CD8+ T cells were significantly increased by DC treatment. These data underscore the feasibility of glioma immunotherapy based on ex vivo transduction of DC with lentiviral vectors.
ISSN: 1043-0342
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Molecular Virology and Gene Therapy
Laboratory of Clinical Immunology
Laboratory of Pediatric Immunology
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.